Prospective evaluation of glucose metabolism in patients undergoing coronary artery bypass grafting

Kardiologia Polska

Volumn 64, Issue 11, 2006, Pages 1187-1193

  Greberski, Krzysztof ^a,c   Guzik, Przemysław ^b   Wysocki, Henryk ^b   Kalawski, Ryszard ^a  

^a J Strus Hospital   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c Oddzial Kardiochirurgii   (Poland)

Author keywords

Coronary artery bypass grafting; Glucose metabolism disturbances; Ischaemic heart disease

Indexed keywords

GLUCOSE;

ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL EXAMINATION; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL EXAMINATION; PREVALENCE;

EID: 33845504323     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.
2. Tatoń J, Czech A. Angiotoksyczność hiperglikemii jako problem kliniczny. Terapia 2004; 12: 2-4.
3. Bartnik M, Malmberg K, Norhammar A, et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004; 25: 1990-7.
4. Total prevalence of diabetes among people aged 20 years or older, United States, 2002. Source: 1999-2001 National Health Interview Survey and 1999-2000 National Health and Nutrition Examination Survey estimates projected to year 2002.
5. Mooy JM, Grootenhuis PA, Vries H, et al. Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study. Diabetes Care 1995; 18: 1270-3.
6. Pyorala K, Lehto S, De Bacquer D, et al. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys. Diabetologia 2004; 47: 1257-65.
7. Cohen Y, Raz I, Merin G, et al. Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium. Am J Cardiol 1998; 81: 7-11.
8. Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999; 67: 1045-52.
9. Grossi EA, Esposito R, Harris LJ, et al. Sternal wound infections and use of internal mammary artery grafts. J Thorac Cardiovasc Surg 1991; 102: 342-7.
10. Morris JJ, Smith LR, Jones RH, et al. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation 1991; 84: III275-84.
11. Bartnik M, Malmberg K, Hamsten A, et al. bnormal glucose tolerance - a common risk factor in patients with acute myocardial infarction in comparison with population-based controls. J Intern Med 2004; 256: 288-97.
12. Bartnik M, Rydén L, Ferrari R. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur H Journal 2004; 21: 1880-90.
13. st Ed. Oxford, Oxford University Press 1999: 124-5.
14. Kuan P, Berstein SB, Ellestad MH. Coronary artery bypass surgery morbidity. J Am Coll Cardiol 1984; 3: 1391-7.
15. Zacharias A, Habib RH. Factors predisposing to median sternotomy complications. Deep vs superficial infection. Chest 1996; 110: 1173-8.
16. Carson JL, Scholz PM, Chen AY, et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002; 40: 418-23.
17. Standards of Medical Care in Diabetes, American Diabetes Association. Diabetes Care 2005; 28: S4-36.
18. Abramov D, Tamariz MG, Fremes SE, et al. Trends in coronary artery bypass surgery results: a recent, 9-year study. Ann Thorac Surg 2000; 70: 84-90.
19. Lauruschkat AH, Arnrich B, Albert AA, et al. Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. Circulation 2005; 112: 2397-402.
20. Anderson RE, Klerdal K, Ivert T, et al. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery? Eur Heart J 2005; 26: 1513-8.
21. de Vegt F, Dekker JM, Stehouwer CD, et al. The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care 1998; 21: 1686-90.
22. Unwin N, Shaw J, Zimmet P, et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708-23.
23. Donnelly R, Emslie-Smith AM, Gardner ID, et al. ABC of arterial and venous disease: vascular complications of diabetes. BMJ 2000; 320: 1062-6.
24. Mahgoub MA, Abd-Elfattah AS. Diabetes mellitus and cardiac function. Mol Cell Biochem 1998; 180: 59-64.
25. A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999. Diabet Med 1999; 16: 716-30.
26. Zalecenia kliniczne dotycza̧ce postȩpowania u chorych na cukrzycȩ 2006. Stanowisko Polskiego Towarzystwa Diabetologicznego. Medycyna Praktyczna 2006; 3: 111-5.